When Kayode Ojo first fell sick with malaria as a young boy in Nigeria, his grandfather shunned modern medicine, venturing into the bush to search for herbs and plants to treat the disease.
Having succumbed to malaria a further 50 or more times in his life, the US-based scientist, now in his 40s, is determined that his research — to develop a drug to stop transmission from humans back to mosquitoes — helps to eradicate the deadly disease.
“When people in Nigeria, the world’s hardest-hit country, get malaria, many simply shrug their shoulders and see it as normal ... that needs to change,” Ojo said in a laboratory at the University of Washington in Seattle.
Illustration: Mountain People
Ojo is one of thousands of scientists, engineers and entrepreneurs striving to develop innovations to end malaria in a city dubbed the “Silicon Valley of saving lives,” which boasts more than 160 organizations working on global health issues.
It is also home to the world’s richest couple, Bill and Melinda Gates, whose global health and education charity has set the aim of eradicating the disease by 2040.
The world has made huge strides against malaria since 2000, with death rates plunging by 60 percent and at least 6 million lives saved globally, the WHO said.
Yet efforts to end one of the world’s deadliest diseases — which killed an estimated 438,000 people last year — are under threat as mosquitoes become increasingly resistant to measures such as insecticide-treated bed nets and anti-malarial drugs.
To combat rising resistance, Seattle’s malaria-fighting community is developing innovations ranging from data modeling and genetic modification to single-dose drugs and sugar traps.
However, malaria spending, which rose to US$2.7 billion annually last year from US$130 million in 2000, must double over the next decade to ensure new solutions outpace drug and insecticide resistance in the push to achieve global eradication by 2040, experts said.
‘NEW TOOLS’
“We need to develop new tools that make it possible to find and root out every parasite in every person,” said Martin Edlund, chief executive of campaign group Malaria No More. “The only way to eradicate malaria is with relentless innovation.”
Gates’ goal of permanently ending transmission of malaria between humans and mosquitoes is more ambitious than the UN Sustainable Development Goal of ending epidemic levels by 2030.
This focus on eradication has accelerated the need to innovate and take more risks, said David Brandling-Bennett, senior adviser for malaria at the Bill & Melinda Gates Foundation.
“We have shifted from ‘any drug or vaccine is good’ to ‘what will be a game changer in pursuit of this outrageous goal?’” he said.
The Gates Foundation and its partners are working on affordable technologies including eave tubes installed between walls and roofs of homes that kill mosquitoes when they try to enter, and outdoor poisonous traps which exploit their attraction to sugar.
Innovations are also in the pipeline to deal with the challenge posed by asymptomatic carriers — people with a few parasites in their blood who do not fall sick, but can act as a reservoir and spread malaria when mosquitoes bite them again.
Scientists are striving to improve rapid diagnostic tests — which require a drop of blood to provide a diagnosis within 20 minutes — so that they can also detect these malaria carriers.
“The challenge is making the test more sensitive, but keeping it simple for health workers,” said Kevin Nichols of patent firm Intellectual Ventures, which works with the Gates Foundation on the Global Good initiative — creating innovations in developing countries.
One of the most cutting-edge approaches among Seattle’s scientists is genetically modifying mosquitoes, either by adding genes to block the malaria parasite, or altering them to make most offspring male, which could cause populations to plummet.
However, this “gene drive” approach has raised questions ranging from the impact of fewer mosquitoes on the food chain to how to regulate releasing genetically edited mosquitoes into the wild.
“There is an ethical question about editing mosquitoes’ DNA,” said a scientist who asked to not be named due to the work of his organization. “We have to be careful about playing God.”
While innovations to alter, control or kill mosquitoes catch the eye, drugs and vaccines should not be neglected given that parasite-carrying people travel further and live longer than mosquitoes, said Bruno Moonen, malaria deputy director at the Gates Foundation.
VACCINES
More than 30 malaria vaccines are under development, with Seattle’s scientists hoping for more success than the first approved vaccine, called RTS,S or Mosquirix, which is only partially effective and needs to be administered in four doses.
Yet a single-dose cure that would wipe out all parasites in humans could soon replace existing artemisinin combination treatment drugs, which must be taken over three days.
“When people fail to complete the course, it increases the risk of resistance developing, and this is a worry,” said Larry Slutsker, malaria program leader at health organization PATH.
Counterfeit malaria drugs in sub-Saharan Africa are another concern to health experts as they contain no artemisinin, leaving people sick, or substandard amounts, which increases resistance, said Ben Wilson, a senior research scientist at Intellectual Ventures.
Wilson and his peers have developed a tool which uses light waves to instantly analyze malaria tablets in a region where as many as one in 10 drugs are estimated to be fake or substandard.
“Counterfeit anti-malarials are a billion-dollar industry, and new technologies are needed to stay ahead of criminal networks,” said Wilson, adding that the tool could soon be adopted by state inspectors, pharmacies and aid agencies.
Outside of the malaria-focused laboratories dotted around Seattle, experts are turning to data in the fight to end the disease.
“Data used to be stuck in spreadsheets,” said Neal Myrick of computer software company Tableau.
“How can you make sense of that?” he added, pointing to a database consisting of 300,000 entries before showing off an interactive heat map in its place.
Detailed maps on prevalence, mortality, treatment rates and use of bed nets, and data modelling tools, allow users to monitor malaria cases, track the origin and predict its spread.
“Innovations to fight malaria are exciting, but surveillance is essential to enable scarce resources to be best spent to make the biggest impact,” said Stephen Lim of the Institute for Health Metrics and Evaluation at the University of Washington.
It is the issue of limited resources that troubles many of those fighting to eradicate malaria by 2040 — who calculate that more than US$100 billion would be needed to finish the job.
In a region such as sub-Saharan Africa, home to nine in 10 of the world’s malaria deaths, domestic spending on the disease would need to rise considerably in the coming years, experts said.
FUNDING FEARS
Yet this might prove difficult in countries such as Nigeria and the Democratic Republic of the Congo (DR Congo) — they account for 40 percent of global malaria deaths — which are struggling economically.
“In [DR Congo] ... we see drug shortages, issues with payments to health workers and irregular distributions of bed nets,” said Marit De Wit, health advisor for Medecins Sans Frontieres in the DR Congo. “The parasite has a free ride in parts of the country.”
Health experts also fear that as the number of cases falls, it would become harder to maintain the momentum to eradicate malaria among donors, governments and people in endemic regions.
Yet for Seattle’s scientists and innovators, such as Ojo, such concerns are no obstacle to their hunt for solutions.
“When I caught malaria for the 40th or 50th time, I realized that it never gets any better, or any easier,” he said of the disease, which can strike a patient several times a year. “It made me realize that we need to innovate and strive not just to treat or control the disease, but to end it for good.”
Malaria No More and the Washington Global Health Alliance provided a travel grant for this story.
Additional reporting by Aaron Ross
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.
As Maldivian President Mohamed Muizzu’s party won by a landslide in Sunday’s parliamentary election, it is a good time to take another look at recent developments in the Maldivian foreign policy. While Muizzu has been promoting his “Maldives First” policy, the agenda seems to have lost sight of a number of factors. Contemporary Maldivian policy serves as a stark illustration of how a blend of missteps in public posturing, populist agendas and inattentive leadership can lead to diplomatic setbacks and damage a country’s long-term foreign policy priorities. Over the past few months, Maldivian foreign policy has entangled itself in playing
A group of Chinese Nationalist Party (KMT) lawmakers led by the party’s legislative caucus whip Fu Kun-chi (?) are to visit Beijing for four days this week, but some have questioned the timing and purpose of the visit, which demonstrates the KMT caucus’ increasing arrogance. Fu on Wednesday last week confirmed that following an invitation by Beijing, he would lead a group of lawmakers to China from Thursday to Sunday to discuss tourism and agricultural exports, but he refused to say whether they would meet with Chinese officials. That the visit is taking place during the legislative session and in the aftermath